Initially, our focus was on the cultivation and rearing of low-THC hemp plants as a raw material for further processing in medicine and industry. The plants were cultivated in a climate-controlled indoor production facility. Right from the start it was important to us that the hemp genetics we used had a therapeutic benefit. We have achieved this with the hemp strain «CBD Therapy».
Our first own product, which we launched under the Ahmea GREEN® brand, was the tobacco substitute product “Ahmea GREEN® – CBD Therapy” at the beginning of 2018. Our product was very well received in our target group at the time and enjoyed great popularity.